Cargando…

Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults

BACKGROUND: Risk of experiencing a systemic adverse event (AE) after mRNA coronavirus disease 2019 (COVID-19) vaccination may be greater among persons with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; data on serious events are limited. We assessed if adults r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tompkins, Lindsay K., Baggs, James, Myers, Tanya R., Gee, Julianne M., Marquez, Paige L., Kennedy, Sharon B., Peake, David, Dua, Dhruv, Hause, Anne M., Strid, Penelope, Abara, Winston, Rossetti, Rebecca, Shimabukuro, Tom T., Shay, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622386/ https://www.ncbi.nlm.nih.gov/pubmed/36372665 http://dx.doi.org/10.1016/j.vaccine.2022.10.073

Ejemplares similares

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
por: Wong, Karen K, et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
por: Chapin-Bardales, Johanna, et al.
Publicado: (2021)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
por: Abara, Winston E., et al.
Publicado: (2023)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022
por: Woo, Emily Jane, et al.
Publicado: (2023)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
por: Gee, Julianne, et al.
Publicado: (2021)

SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020
por: Panagiotakopoulos, Lakshmi, et al.
Publicado: (2020)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

Identification of boosepivirus B in U.S. calves
por: Hause, Ben M., et al.
Publicado: (2021)

U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines
por: Gubernot, Diane, et al.
Publicado: (2021)

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
por: Shimabukuro, Tom T., et al.
Publicado: (2021)

HIV Screening Rates among Medicaid Enrollees Diagnosed with Other Sexually Transmitted Infections
por: Adekeye, Oluwatoyosi A., et al.
Publicado: (2016)

Bovine Rhinitis Viruses Are Common in U.S. Cattle with Bovine Respiratory Disease
por: Hause, Ben M., et al.
Publicado: (2015)

Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination
por: Yih, W Katherine, et al.
Publicado: (2003)

Syphilis Trends among Men Who Have Sex with Men in the United States and Western Europe: A Systematic Review of Trend Studies Published between 2004 and 2015
por: Abara, Winston E., et al.
Publicado: (2016)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

Heat-related mortality in U.S. state and private prisons: A case-crossover analysis
por: Skarha, Julianne, et al.
Publicado: (2023)

U–Th whole rock data and high spatial resolution U–Th disequilibrium and U–Pb zircon ages of Mt. Erciyes and Mt. Hasan Quaternary stratovolcanic complexes (Central Anatolia)
por: Friedrichs, Bjarne, et al.
Publicado: (2020)

147. Opportunities for Improving Urine Culturing Practices in U.S. Acute Care Hospitals, 2017-2020
por: Asonganyi, Nyawung, et al.
Publicado: (2023)

Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14()
por: Foppa, Ivo M., et al.
Publicado: (2015)

Bots, disinformation, and the first impeachment of U.S. President Donald Trump
por: Rossetti, Michael, et al.
Publicado: (2023)

Predicting U.S. Tuberculosis Case Counts through 2020
por: Woodruff, Rachel S. Y e l k, et al.
Publicado: (2013)

Analytical data on respiratory symptoms and pulmonary impairments due to exposure to non-combusted liquefied petroleum gas
por: Akpan, Emmanuel, et al.
Publicado: (2021)

2455. National Trends in the Rates of Drug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-2021
por: Baggs, James, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t72lpm47jr8ktbovefu727hshl